《中国药典》2020年版含黄芪成方制剂分析及其现代研究进展

通过查阅《中华人民共和国药典》（以下简称《中国药典》）2020年版（一部），统计其中收载的含黄芪成方制剂，归纳整理其中药味数、制剂剂型、功效主治、禁忌事项及主要药对，并对相关的临床应用和药理作用研究进行综述。结果发现，《中国药典》2020年版共收载了224种含黄芪的成方制剂，包括40种炙黄芪的成方制剂，处方用药味数以6~10味居多，制剂剂型以颗粒剂居多，功效主治以补益气血为主，禁忌事项则以孕妇禁忌居多。可为黄芪的临床新应用、新功效挖掘、新剂型改良及黄芪成方制剂的深度开发提供参考。

Analysis and Modern Research Progress of Formulas Containing Astragali Radix in Chinese Pharmacopoeia (2020 Edition)

Formulas containing Astragali Radix in Chinese Pharmacopoeia (2020 Edition) were statistically analyzed. To be specific, the number of medicinals in the formulas, the dosage forms, indications, contraindications, and the main medicinal pairs were summed up, and the clinical applications and pharmacological actions were reviewed. The results showed that Chinese Pharmacopoeia recorded 224 formulas containing Astragali Radix, with 40 containing Astragali Radix Preparata. The number of medicinals used in most of the formulas fell in the range of 6-10, and most the formulas were granules. Moreover, the majority of the formulas had the functions of tonifying and replenishing qi and blood with the taboo for pregnant women. To sum up, this review is expected to serve as a reference for the clinical application, exploration of novel functions, improvement of dosage form, and further development of Astragali Radix.